Menu
 
Research menu
Jump to menu

Publications:  Miss Belinda Nedjai

Ramírez AT, Sánchez GI, Nedjai B, Agudelo MC, Brentnall A, Cuschieri K, Castañeda KM, Cuzick J et al.(2020). Effective methylation triage of HPV positive women with abnormal cytology in a middle- 2 income country. International Journal of Cancer
10.1002/ijc.33314
https://qmro.qmul.ac.uk/xmlui/handle/123456789/67764
Giuliano AR, Nedjai B, Lorincz AT, Schell MJ, Rahman S, Banwait R, Boulware D, Sirak B et al.(2020). Methylation of HPV 16 and EPB41L3 in oral gargles: Associations with oropharyngeal cancer detection and tumor characteristics. International Journal of Cancer vol. 146, (4) 1018-1030.
10.1002/ijc.32570
https://qmro.qmul.ac.uk/xmlui/handle/123456789/58964
Nedjai B, Hernández-López R, Lorincz A, Torres-Ibarra L, Reuter C, Scibior-Bentkowska D, Warman R, Mendiola-Pastrana I et al.(2019). Methylation estimates the risk of precancer in HPV-infected women with discrepant results between cytology and HPV16/18 genotyping. Clinical Epigenetics
10.1186/s13148-019-0743-9
https://qmro.qmul.ac.uk/xmlui/handle/123456789/61917
Louvanto K, Aro K, Nedjai B, Bützow R, Jakobsson M, Kalliala I, Dillner J, Nieminen P et al.(2019). Methylation in predicting progression of untreated high-grade cervical intraepithelial neoplasia. Clinical Infectious Diseases
10.1093/cid/ciz677
https://qmro.qmul.ac.uk/xmlui/handle/123456789/59539
Cuschieri K, Lorincz AT, Nedjai B(2019). Human Papillomavirus Research: Where Should We Place Our Bets?. Acta Cytol vol. 63, (2) 85-96.
10.1159/000493800
https://qmro.qmul.ac.uk/xmlui/handle/123456789/58761
Nedjai B, Reuter C, Ahmad A, Banwait R, Warman R, Carton J, Boer S, Cuzick J et al.(2018). Molecular progression to cervical precancer, epigenetic switch or sequential model?. International Journal of Cancer vol. 143, (7) 1720-1730.
10.1002/ijc.31549
https://qmro.qmul.ac.uk/xmlui/handle/123456789/39447
Bagnati M, Ogunkolade BW, Marshall C, Tucci C, Hanna K, Jones TA, Bugliani M, Nedjai B et al.(2016). Glucolipotoxicity initiates pancreatic β-cell death through TNFR5/CD40-mediated STAT1 and NF-κB activation. Cell Death and Disease vol. 7, (8)
10.1038/cddis.2016.203
https://qmro.qmul.ac.uk/xmlui/handle/123456789/15134
Nedjai B, Viney JM, Li H, Hull C, Anderson CA, Horie T, Horuk R, Vaidehi N et al.(2015). CXCR3 antagonist VUF10085 binds to an intrahelical site distinct from that of the broad spectrum antagonist TAK-779. British Journal of Pharmacology vol. 172, (7) 1822-1833.
10.1111/bph.13027
Turner MD, Nedjai B, Hurst T, Pennington DJ(2014). Cytokines and chemokines: At the crossroads of cell signalling and inflammatory disease. Biochimica et Biophysica Acta - Molecular Cell Research vol. 1843, (11) 2563-2582.
10.1016/j.bbamcr.2014.05.014
Nedjai B, Li H, Stroke IL, Wise EL, Webb ML, Merritt JR, Henderson I, Klon AE et al.(2012). Small molecule chemokine mimetics suggest a molecular basis for the observation that CXCL10 and CXCL11 are allosteric ligands of CXCR3. British Journal of Pharmacology vol. 166, (3) 912-923.
10.1111/j.1476-5381.2011.01660.x
https://qmro.qmul.ac.uk/xmlui/handle/123456789/58963
Turner MD, Chaudhry A, Nedjai B(2012). Tumour necrosis factor receptor trafficking dysfunction opens the TRAPS door to pro-inflammatory cytokine secretion. Bioscience Reports vol. 32, (2) 105-112.
10.1042/BSR20110089
Nedjai B, Hitman GA, Church LD, Minden K, Whiteford ML, McKee S, Stjernberg S, Pettersson T et al.(2011). Differential cytokine secretion results from p65 and c-Rel NF-κB subunit signaling in peripheral blood mononuclear cells of TNF receptor-associated periodic syndrome patients. Cellular Immunology vol. 268, (2) 55-59.
10.1016/j.cellimm.2011.02.007
Nedjai B, Quillinan N, Coughlan RJ, Church L, McDermott MF, Hitman GA, Turner MD(2010). Lessons from anti-TNF biologics: infliximab failure in a TRAPS family with the T50M mutation in TNFRSF1A. Advances in Tnf Family Research; Proceedings from the 12th International TNF Conference, 2009., Editors: Wallach, D, Kovalenko, A, Feldmann, M, vol. 691, Springer (New York),
Hall SE, Mao A, Nicolaidou V, Finelli M, Wise EL, Nedjai B, Kanjanapangka J, Harirchian P et al.(2009). Elucidation of binding sites of dual antagonists in the human chemokine receptors CCR2 and CCR5. Molecular Pharmacology vol. 75, (6) 1325-1336.
10.1124/mol.108.053470
Nedjai B, Hitman GA, Quillinan N, Coughlan RJ, Church L, McDermott MF, Turner MD(2009). Proinflammatory action of the antiinflammatory drug infliximab in tumor necrosis factor receptor-associated periodic syndrome. Arthritis and Rheumatism vol. 60, (2) 619-625.
10.1002/art.24294
Churchman SM, Church LD, Savic S, Coulthard LR, Hayward B, Nedjai B, Turner MD, Mathews RJ et al.(2008). A novel TNFRSF1A splice mutation associated with increased nuclear factor kappa appaB (NF-kappa B) transcription factor activation in patients with tumour necrosis factor receptor associated periodic syndrome (TRAPS). ANN RHEUM DIS vol. 67, (11) 1589-1595.
10.1136/ard.2007.078667
Turner MD, Nedjai B, Hitman GA, McDermott M(2008). Cell surface expression of TNFRI in tumor necrosis factor receptor-associated periodic syndrome: comment on the article by Nedjai et al - Reply. ARTHRITIS RHEUM vol. 58, (7) 2214-2215.
10.1002/art.23547
Nedjai B, Hitman G, Yousaf N, Chernajovsky Y, Stjernberg-Salmela S, Pettersson T, Ranki A, Hawkins P et al.(2008). Abnormal TNFR1 cell surface expression and NF-kappaB activation in TNFR1-Associated Periodic Fever Syndrome (TRAPS). CLIN EXP RHEUMATOL vol. 26, (2) 182-182.
Nedjai B, Hitman GA, Yousaf N, Chernajovsky Y, Stiernberg-Salmela S, Pettersson T, Ranki A, Hawkins PN et al.(2008). Abnormal tumor necrosis factor receptor I cell surface expression and NF-kappa B activation in tumor necrosis factor receptor-associated periodic syndrome. ARTHRITIS RHEUM vol. 58, (1) 273-283.
10.1002/art.23123
Return to top